(Q95445296)
Statements
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2 (English)
Patrick Hwu
Elizabeth Buchbinder
Jeanette E Eckel-Passow
Ruchi Sharma
Ping Liu
Alexander Parker
John Jakob
Roland L Bassett
Michael A Davies
Michael B Atkins